JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.960
+0.100 (5.38%)
At close: Mar 27, 2026

HKG:2126 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-590.62-768-846.14-702.33
Depreciation & Amortization
83.6793.7781.3746.33
Other Amortization
5.996.065.711.9
Loss (Gain) From Sale of Assets
-0.930.170.12
Asset Writedown & Restructuring Costs
132.26181.21--
Stock-Based Compensation
37.3134.9782.589.37
Other Operating Activities
27.7749.45164.76-46.37
Change in Accounts Receivable
-35.22-36.64-5.31-
Change in Inventory
3.525.38-8.76-28.78
Change in Unearned Revenue
-14.2230.42--
Change in Other Net Operating Assets
16.14.02-11.0378.57
Operating Cash Flow
-333.44-398.42-536.72-561.2
Capital Expenditures
-5.22-12.41-76.87-73.09
Sale of Property, Plant & Equipment
-0.080.05-
Sale (Purchase) of Intangibles
-10.15-2.17-23.71-64.04
Other Investing Activities
-0.0624.4-23.55-
Investing Cash Flow
-15.439.9-124.08-137.13
Long-Term Debt Issued
327.95210234.8-
Long-Term Debt Repaid
-225.71-197.34-115.75-13.02
Net Debt Issued (Repaid)
102.2412.66119.05-13.02
Issuance of Common Stock
0.40.030.090.7
Other Financing Activities
-12.16-12.42-6.79-18.3
Financing Cash Flow
90.490.28112.35-30.62
Foreign Exchange Rate Adjustments
9.8410.8197.39-67.25
Net Cash Flow
-248.53-377.43-451.06-796.2
Free Cash Flow
-338.67-410.83-613.6-634.29
Free Cash Flow Margin
-214.05%-236.30%-421.13%-2059.57%
Free Cash Flow Per Share
-0.82-1.00-1.50-1.59
Cash Interest Paid
12.1612.426.795.91
Levered Free Cash Flow
-227.7-218.11-428.1-575.04
Unlevered Free Cash Flow
-220.06-210.35-423.86-573.36
Change in Working Capital
-29.813.19-25.149.79
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.